Breast Medical Oncology ...

Dr. Karng S. Log

Claim this profile

Lutheran Hospital - Cancer Centers of Colorado

Studies Cancer
Studies Small Cell Lung Cancer
10 reported clinical trials
32 drugs studied

Area of expertise

1

Cancer

Karng S. Log has run 3 trials for Cancer. Some of their research focus areas include:

p16 positive
p16 negative
Stage IV
2

Small Cell Lung Cancer

Karng S. Log has run 2 trials for Small Cell Lung Cancer.

Affiliated Hospitals

Image of trial facility.

Lutheran Hospital - Cancer Centers Of Colorado

Image of trial facility.

SCL Health Saint Joseph Hospital

Clinical Trials Karng S. Log is currently running

Image of trial facility.

Chemotherapy + Immunotherapy

for Esophageal and Gastric Cancer

This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.

Recruiting

2 awards

Phase 3

2 criteria

Image of trial facility.

Biobank Collection

for Cancer

This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking at samples and information collected from the same people over time, researchers hope to better understand how cancer changes over time and over the course of medical treatments.

Recruiting

1 award

N/A

10 criteria

More about Karng S. Log

Clinical Trial Related

3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical Trials

Treatments Karng S. Log has experience with

  • Oxaliplatin
  • MFOLFIRINOX
  • Carboplatin/Cisplatin-Etoposide
  • HLX10
  • Prophylactic Cranial Irradiation (PCI)
  • Thoracic Radiotherapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Karng S. Log specialize in?

Is Karng S. Log currently recruiting for clinical trials?

Are there any treatments that Karng S. Log has studied deeply?

What is the best way to schedule an appointment with Karng S. Log?

What is the office address of Karng S. Log?

Is there any support for travel costs?